Matthew E. Winter
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Hartford Closes Equitable Benefits Deal, Faces Lower Price Targets. The Hartford has completed its acquisition of Equitable’s employee benefits business, aiming to strengthen that segment. Following the deal, several analysts, including Keefe, Bruyette & Woods and Wells Fargo, lowered their price targets. The stock is currently trading near its 52-week high, with a P/E ratio of 8.3.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
HRB Featured in Recent Dividend and Growth Stock Lists. SeekingAlpha called HRB a stable business with attractive returns. A dividend champion article highlighted HRB as a contender for dividend-focused investors. A Yahoo piece on bookkeeping and payroll underscored the relevance of HRB’s core services in the current market.
Transaction History
| ADT | ▲ Buy | Grant | 235 | $0 | 10/1/2026 | View on chart |
| HIG | ▲ Buy | Grant | 1,356 | $190K | 7/27/2026 | View on chart |
| ADT | ▲ Buy | Grant | 210 | $0 | 7/7/2026 | View on chart |
| ADT | ▲ Buy | Grant | 26,354 | $0 | 5/27/2026 | View on chart |
| ADT | ▲ Buy | Grant | 150 | $0 | 4/2/2026 | View on chart |
| ADT | ▲ Buy | Grant | 120 | $0 | 1/8/2026 | View on chart |
| HRB | ▲ Buy | Grant | 3,927 | $0 | 11/5/2025 | View on chart |
| ADT | ▲ Buy | Grant | 112 | $0 | 10/2/2025 | View on chart |
| HIG | ▲ Buy | Grant | 1,525 | $190K | 7/30/2025 | View on chart |
| ADT | ▲ Buy | Grant | 116 | $0 | 7/8/2025 | View on chart |
| ADT | ▲ Buy | Grant | 17,730 | $0 | 5/21/2025 | View on chart |
| ADT | ▲ Buy | Grant | 143 | $0 | 4/10/2025 | View on chart |
| ADT | ▲ Buy | Grant | 164 | $0 | 1/9/2025 | View on chart |
| HRB | ▲ Buy | Grant | 3,148 | $0 | 11/6/2024 | View on chart |
| ADT | ▲ Buy | Grant | 158 | $0 | 10/4/2024 | View on chart |
| HIG | ▲ Buy | Grant | 1,726 | $190K | 7/29/2024 | View on chart |
| ADT | ▲ Buy | Grant | 158 | $0 | 7/9/2024 | View on chart |
| ADT | ▲ Buy | Grant | 20,576 | $0 | 5/22/2024 | View on chart |
| ADT | ▲ Buy | Grant | 148 | $0 | 4/4/2024 | View on chart |
| ADT | ▲ Buy | Grant | 90 | $0 | 1/9/2024 | View on chart |
| HRB | ▲ Buy | Grant | 4,540 | $0 | 11/3/2023 | View on chart |
| ADT | ▲ Buy | Grant | 93 | $578 | 10/4/2023 | View on chart |
| HIG | ▲ Buy | Grant | 2,504 | $180K | 7/31/2023 | View on chart |
| ADT | ▲ Buy | Grant | 96 | $0 | 7/6/2023 | View on chart |
| ADT | ▲ Buy | Grant | 16,556 | $0 | 5/24/2023 | View on chart |
| ADT | ▲ Buy | Grant | 72 | $0 | 4/4/2023 | View on chart |
| ADT | ▲ Buy | Grant | 54 | $0 | 1/4/2023 | View on chart |
| HRB | ▲ Buy | Grant | 4,679 | $0 | 11/4/2022 | View on chart |
| ADT | ▲ Buy | Grant | 60 | $0 | 10/4/2022 | View on chart |
| HIG | ▲ Buy | Grant | 2,838 | $180K | 8/1/2022 | View on chart |
| ADT | ▲ Buy | Grant | 76 | $0 | 7/5/2022 | View on chart |
| ADT | ▲ Buy | Grant | 13,908 | $0 | 5/25/2022 | View on chart |
| ADT | ▲ Buy | Grant | 45 | $0 | 4/4/2022 | View on chart |
| ADT | ▲ Buy | Grant | 40 | $0 | 1/4/2022 | View on chart |
| ADT | ▲ Buy | Grant | 41 | $0 | 10/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
ADT Inc. Featured as 10‑Bagger Candidate and Value Stock
ADT Inc. has drawn attention in recent market commentary. Benzinga named it one of three unlikely stocks with 10‑bagger potential, while Yahoo included it on a value‑stock watchlist. The company trades at a low P/E of 7.0 and offers a 2.34% dividend yield. Analysts average a target price of $8.23, within its 52‑week range.
ADT Inc. Featured as 10‑Bagger Candidate and Value Stock. ADT Inc. has drawn attention in recent market commentary. Benzinga named it one of three unlikely stocks with 10‑bagger potential, while Yahoo included it on a value‑stock watchlist. The company trades at a low P/E of 7.0 and offers a 2.34% dividend yield. Analysts average a target price of $8.23, within its 52‑week range.